Home / VA / In-Vitro Diagnostic Substance Manufacturing / Notice

Blood Bank Reagents

Updated

Sources Sought from the Department of Veterans Affairs, for work in Dallas, Texas. Due Nov 5, 2026, 9:00 AM (UTC-6), 7 days left.

Be among the first to see new In-Vitro Diagnostic Substance Manufacturing contracts
Only new notices that match, once a day.
Title as posted6550--Blood Bank Reagents
Solicitation number36C25727Q0065
AgencyDepartment of Veterans Affairs
Office257-Network Contract Office 17 (36C257)
Notice typeSources Sought
Set-asideNone
Trade (NAICS)In-Vitro Diagnostic Substance Manufacturing (325413)
Product or service code6550
Place of performanceDallas, Texas
PostedOct 28, 2026
Response deadlineNov 5, 2026, 9:00 AM (UTC-6) (7 days left)
Add the deadline toGoogle Calendar · Apple / Outlook (.ics)
Official notice
Send to a teammate

Bid documents (1)

Paid members download every document from this page, or buy this bid alone.

Federal prevailing wage rates for this place: Texas Davis-Bacon and SCA wage determinations.

Description

This is a sources sought notice only. This notice does NOT constitute a request for quote (RFQ), request for proposal (RFP), or invitation for bid (IFB). No solicitation is currently available.

This Sources Sought is issued solely for information and planning purposes to conduct market research and determine the availability and capability of qualified sources prior to determining the appropriate acquisition strategy. I. General Information - Agency/Office: Department of Veterans Affairs (VA), VA North Texas Health Care System (VANTHCS), 4500 S. Lancaster Rd. Dallas, TX.

75216 - Place of Performance: VA North Texas Health Care System, Pathology and Laboratory Medicine Service (P&LMS), Microbiology Laboratory, Dallas, Texas. - Anticipated NAICS: 325413 In-Vitro Diagnostic Substance Manufacturing - Anticipated PSC: 6550 In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets. The Government is seeking to identify responsible vendors capable of providing Blood Bank Reagents, used to perform patient manual blood typing and serum antibody detection and identification to be used in the Transfusion Medicine Unit, Pathology and Laboratory Medicine Services at VANTHCS.

II. Description of Requirement Transfusion Medicine Unit, Pathology and Laboratory Medicine Services (P&LMS) at the VA North Texas Health Care System (VANTHCS), Dallas, TX is seeking blood reagents used to perform patient manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions. The contemplated purchase includes, at a minimum: The Contractor shall provide reagent supplies as requested by VANTHCS staff to perform blood bank manual blood typing and serum antibody detection and identification testing used for cross matching blood for transfusions.

Estimated Yearly Requirements: Item # Description/Part Number* Qty Unit 1 Z401U, ALBAcyte A1 Cells 52 EA 2 Z406U, ALBAcyte A2 Cells 13 EA 3 Z411U, ALBAcyte B Cells 52 EA 4 Z4411U-1, ALBAcyte IgG Sensitized Cells (weak) 26 EA 5 Z473U, ALBAcyte Antibody ID Panel (16-cell) 7 EA 6 Z482U, ALBAcyte C3 Coated Red Blood Cells 13 EA Period of Performance: Base Year: 05/01/2027-04/30/2028 Option Year 1: 05/01/2028-04/30/2029 Option Year 2: 05/01/2029-04/30/2030 Option Year 3: 05/01/2030-04/30/2031 Option Year 4: 05/01/2031-04/30/2032 Location: The manual testing will be performed in Transfusion Medicine Unit, Pathology & Laboratory Medicine Service, VA North Texas Health Care System, 4500 S. Lancaster Rd., Dallas, TX 75216.

III. Performance requirements: Performance Requirements: The following are required: Packing and Delivery: All Shipping/Freight Charges will be FOB Destination unless noted otherwise by vendor and communicated to the contracting officer prior to award. The reagents shall be delivered at the time specified when the order is placed.

The Contractor will furnish appropriate containers for shipment of the reagents. Vendor must be approved by the FDA and shall provide documentation of approval. Vendor must have a defined Quality plan, and Adequate supplies available.

IV. Submission Instructions Interested and capable vendors should submit an electronic capability statement and include the place of manufacture for all reagents listed in the sources sought via email in PDF or Word format by November 5, 2026, by 9:00 AM Central Standard Time. - Teresa Arzola - Email: [email protected] - Subject line: Sources Sought Blood Bank Reagents VA North Texas HCS No telephone inquiries will be accepted.

Responses received will be used solely for market research and planning purposes to assist the Government in determining an appropriate acquisition strategy (e.g., small business set aside or unrestricted). Submission of a capability statement is voluntary and shall not be construed as a commitment by the Government to issue a solicitation or award a contract, nor will the Government pay for information submitted in response to this Sources Sought.

Contracting contact

As published on the official notice. Ask questions in writing and before any questions deadline the notice sets.

Is your business small enough?

For NAICS 325413, a business counts as small if it has no more than 1,250 employees (SBA size standard). This notice is not set aside, but the size decides your small business status on it. SBA table, current as of Oct 15, 2026.

Companies that win this kind of work

Federal contractors paid for in-vitro diagnostic substance manufacturing work, who also hold VA contracts (last 12 months): possible competitors, or partners to team with.

About the buyer

The Department of Veterans Affairs awarded $84.6 billion in contracts in the last 12 months; its biggest suppliers were Optum Public Sector Solutions, Inc., Mckesson Corporation and Triwest Healthcare Alliance Corp. See what VA is buying now.

In-Vitro Diagnostic Substance Manufacturing contracts right now

There are 18 open government contract opportunities in this trade (NAICS 325413), 6 posted in the last 7 days; 28% are set aside for small businesses. The agencies buying the most are Department of Veterans Affairs, Defense Health Agency (DHA) and National Institutes of Health. Most of the work with a stated place is in Texas, Washington and South Carolina. A notice in this trade gives a median of 14 days from posting to deadline; this one gives 8 days.

All open in-vitro diagnostic substance manufacturing contracts

Recent awards in this trade

From the award notices agencies publish.

Similar open in-vitro diagnostic substance manufacturing bids

BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems
Defense Health Agency (DHA)
Due Nov 6, 2026, 12:00 PM (UTC-5) · 8 days left
Solicitation · Service-disabled veteran-owned · JBSA Ft Sam Houston, TX · Posted Oct 23, 2026
Dressing, Drawtex 4IN X 4IN (VA-27-00014447)
Department of Veterans Affairs
Due Nov 3, 2026, 3:00 PM (UTC-5) · 5 days left
Sources Sought · Ladson, SC · Posted Oct 28, 2026
Optilite analyzer reagents
Department of Veterans Affairs
Due Nov 4, 2026, 9:00 AM (UTC-8) · 6 days left
Solicitation · Tucson, AZ · Posted Oct 27, 2026
VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ
Department of Veterans Affairs
Due Nov 5, 2026, 10:00 AM (UTC-5) · 7 days left
Solicitation · Various Locations · Posted Oct 22, 2026
NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health
Due Nov 2, 2026, 9:00 AM (UTC-5) · 4 days left
Solicitation · Posted Oct 22, 2026
Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests.
Department of Veterans Affairs
Due Nov 13, 2026, 10:00 AM (UTC-8) · 15 days left
Sources Sought · Seattle, WA · Posted Oct 19, 2026